Role of concentration-dependent plasma protein binding in disopyramide disposition. 1979

P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004206 Disopyramide A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties. Diisopyramide,Disopyramide Monohydrochloride,Disopyramide Phosphate,Disopyramide Phosphate (1:1),Disopyramide Phosphate (1:1), (+-)-Isomer,Disopyramide Phosphate (1:1), (R)-Isomer,Disopyramide Phosphate (1:1), (S)-Isomer,Disopyramide, (+-)-Isomer,Disopyramide, (R)-Isomer,Disopyramide, (S)-Isomer,Disopyramide, D-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:1), (R)-Isomer,Disopyramide, L-Tartrate (1:1), (S)-Isomer,Disopyramide, L-Tartrate (1:2), (+-)-Isomer,Disopyramide, L-Tartrate, (S)-isomer,Norpace,Palpitin,Palpitine,Rhythmodan,Ritmilen,Rythmilen,SC-13957,SC 13957,SC13957
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
January 1984, Clinical pharmacokinetics,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
September 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
August 1984, Life sciences,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
June 1980, British journal of clinical pharmacology,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
December 1981, The Journal of pharmacology and experimental therapeutics,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
January 1979, Clinical pharmacokinetics,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
May 1981, Clinical pharmacology and therapeutics,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
January 1983, Therapeutic drug monitoring,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
January 1987, European journal of clinical pharmacology,
P J Meffin, and E W Robert, and R A Winkle, and S Harapat, and F A Peters, and D C Harrison
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!